Spermosens AB
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SPERM.ST research report →
Companywww.spermosens.com
Spermosens AB engages in the research, development, and commercialization of diagnostic technology in health and medical care in Sweden. The company provides male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding.
- CEO
- Tore Duvold
- IPO
- 2021
- Employees
- 3
- HQ
- Lund, SE
Price Chart
Valuation
- Market Cap
- $29.19M
- P/E
- -3.14
- P/S
- 0.00
- P/B
- 0.97
- EV/EBITDA
- -2.69
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -27.78%
- ROIC
- -30.92%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-9,200,000 · 9.84%
- EPS
- $-0.00 · 93.38%
- Op Income
- $-9,233,000
- FCF YoY
- 0.08%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.14
- Avg Volume
- 5.89M
Get TickerSpark's AI analysis on SPERM.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SPERM.ST Coverage
We haven't published any research on SPERM.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SPERM.ST Report →